1 |
中华医学会感染病学分会肝衰竭与人工肝学组,中华医学会肝病学分会重型肝病与人工肝学组.肝衰竭诊治指南(2018年版)[J].中华肝脏病杂志,2019,27(1):18-26.
|
2 |
石清兰,蓝艳梅,毛德文,等.中西医结合防治HBV相关性肝衰竭的研究进展[J].中西医结合肝病杂志,2018,28(4):253-256.
|
3 |
中华医学会器官移植学分会围手术期管理学组.肝衰竭肝移植围手术期管理中国专家共识(2021版)[J].中华消化外科杂志,2021,20(8):835-840.
|
4 |
王艳红,胡佳佳,巴俊慧,等.人工肝支持急性妊娠脂肪肝性肝衰竭6例[J/CD].中华危重症医学杂志(电子版),2021,14(2):153-155.
|
5 |
吴牧晨,孟庆华.慢加急性肝衰竭患者的营养评估及临床管理[J].临床肝胆病杂志,2021,37(4):770-774.
|
6 |
王水莲,杨芳.预后营养指数对癌症患者预后的临床意义[J].现代肿瘤医学,2019,27(6):1083-1086.
|
7 |
Li D, Yuan X, Liu J, et al. Prognostic value of prognostic nutriational index in lung cancer: a meta-analysis[J]. J Thorac Dis, 2018, 10 (9): 5298-5307.
|
8 |
Abo-Elenein AM, Mabrouk MM, Abou-Saif S, et al. Role of both protein C and antithrombin Ⅲ as predictors of stage of liver disease in chronic viral hepatitis B or C infected patients[J]. Endocr Metab Immune Disord Drug Targets, 2020, 20 (1): 112-117.
|
9 |
Tong JJ, Zhao W, Mu XY, et al. Predictive value of the Chinese group on the study of severe hepatitis B-acute-on-chronic liver failure score in the short-term prognosis of patients with hepatitis B virus-related acute-on-chronic liver failure[J]. Chin Med J (Engl), 2019, 132 (13): 1541-1549.
|
10 |
苗静,郭丽颖,王丽,等. MELD-Na、CLIF-C OFs、COSSH-ACLFs、NLR评分体系在乙型肝炎病毒相关慢加急性肝衰竭患者中的应用价值研究[J].中华危重病急救医学, 2020,32(12):1496-1501.
|
11 |
Ikura A, Chu PS, Nakamoto N, et al. CLIF-C organ failure score and liver volume predict prognosis in steroid-treated severe acute autoimmune hepatitis[J]. Hepatol Commun, 2020, 4 (7): 1019-1033.
|
12 |
Jalan R, Saliba F, Pavesi M, et al. Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure[J]. J Hepatol, 2014, 61 (5): 1038-1047.
|
13 |
Hassan MS, Abd El-Rehim AS, Khalil MA, et al. Nutritional assessment of cirrhotic patients with variable severity[J]. J Curr Med Res Pract, 2019, 4 (2): 144-151.
|
14 |
徐传翀,陈芳,邹蓓蓓,等.预后营养指数在乙型肝炎肝硬化患者病情严重程度及预后评估中的应用[J].慢性病学杂志,2019,20(12):1782-1785.
|
15 |
鲁雅诵,胡博.抗凝血酶Ⅲ活性在几种常见病中的研究[J].世界最新医学信息文摘,2015,15(90):143-144.
|
16 |
Okuno M, Taura K, Kimura Y, et al. Low level of postoperative plasma antithrombin Ⅲ is associated with portal vein thrombosis after liver surgery[J]. Surg Today, 2021, 51 (8): 1343-1351.
|
17 |
Hidaka H, Kokubu S, Sato T, et al. Antithrombin Ⅲ for portal vein thrombosis in patients with liver disease: a randomized, double-blind, controlled trial[J]. Hepatol Res, 2018, 48 (3): E107-E116.
|
18 |
许志坚.慢性肝病患者FDP和抗凝血酶-Ⅲ以及D-二聚体水平检测的意义[J].当代医学,2021,27(22):9-10.
|
19 |
Kawanaka H, Akahoshi T, Kinjo N, et al. Impact of antithrombin Ⅲ concentrates on portal vein thrombosis after splenectomy in patients with liver cirrhosis and hypersplenism[J]. Ann Surg, 2010, 251 (1): 76-83.
|
20 |
吴佳雨,张秉强.红细胞分布宽度在肝脏疾病中的应用进展[J].肝脏,2021,26(5):563-565.
|
21 |
Wang J, Huang R, Yan X, et al. Red blood cell distribution width: a promising index for evaluating the severity and long-term prognosis of hepatitis B virus-related diseases[J]. Dig Liver Dis, 2020, 52 (4): 440-446.
|
22 |
Wu T, Li J, Shao L, et al. Development of diagnostic criteria and a prognostic score for hepatitis B virus-related acute-on-chronic liver failure[J]. Gut, 2018, 67 (12): 2181-2191.
|
23 |
田小利,吴松林,王波,等. COSSH-ACLFs评分模型对HBV相关慢加急性肝衰竭患者短期预后的预测价值[J].临床肝胆病杂志,2020,36(6):1258-1262.
|
24 |
Li Q, Chen C, Huang C, et al. Noninvasive models for predicting poor prognosis of chronic HBV infection patients precipitating acute HEV infection[J]. Sci Rep, 2020, 10 (1): 2753.
|